C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
167/231, 167/237
C07D 207/22 (2006.01) C07D 471/04 (2006.01) C07D 487/04 (2006.01) C07D 513/04 (2006.01)
Patent
CA 1296005
ABSTRACT OF THE DISCLOSURE A diaryl-substituted imidazole fused to a thiazole, pyrrole, thiazine or pyridine ring, or pharmaceutical compositions thereof, are useful in inhibiting the 5-lipoxygenase pathway in an animal in need thereof by administration of an effective, 5-lipoxygenase pathway inhibiting amount of such compound. In particular, the inhibiting compound and pharmaceutical compositions thereof will alleviate the 5-lipoxygenase pathway mediated disease state of rheumatoid arthritis. These compounds do not share the ulcerogenic liability or toxicity of other compounds such as corticosteroids which are used in the treatment of the 5-lipoxygenase pathway.
524908
Bender Paul E.
Hanna Nabil
Bender Paul E.
Gowling Lafleur Henderson Llp
Hanna Nabil
Smith Kline & French Ltd.
Smithkline And French Ltd.
LandOfFree
Inhibition of the 5-lipoxygenase pathway does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibition of the 5-lipoxygenase pathway, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of the 5-lipoxygenase pathway will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1187791